CARISMA Therapeutics Stock Soars 150.23% on Investor Optimism

On September 2, 2025, CARISMA Therapeutics experienced a remarkable surge, with its stock price soaring by 150.23% in the pre-market session.

CARISMA Therapeutics' stock price has been on a rollercoaster ride, with significant volatility in recent trading sessions. The company's shares have shown strong performance after hours, rising by 120.0% to $0.47 during Monday's after-hours session. This surge comes despite a 30.98% decline in the past month, indicating a potential turnaround for the biotech firm.

Investors have been closely monitoring CARISMA Therapeutics due to its innovative approach in the biotechnology sector. The company's recent developments and strategic initiatives have sparked interest among market participants, contributing to the stock's recent price movements. The after-hours gains reflect growing optimism about the company's future prospects and its ability to deliver on its promises.